Streamline Health Competitors and Similar CompaniesClear all
Streamline Health's competitors and similar companies include Advaxis, Immunocore, MOLOGEN and F-star Biotechnology.
 Streamline Health Streamline Health Solutions is a company that develops revenue cycle management software for healthcare providers. |  Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. |  MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. |  F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ||
Founding Date | Founding Date 1989 | Founding Date 2002 | Founding Date 2008 | Founding Date 1998 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Alpharetta, US HQ | Locations Princeton, US HQ | Locations Milton, GB HQ Conshohocken, US Rockville, US | Locations Berlin, DE HQ | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 7824% decrease | Employees 3540% decrease | Employees 493 | Employees 4710% decrease | Employees 39 |
Valuation ($) | Valuation ($) 9.1 m | Valuation ($) 2.4 m | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $17.9m (FY, 2025) | Revenue (est.) $13k (FY, 2023) | Revenue (est.) $400m (FY, 2025) | Revenue (est.) €81k (FY, 2019) | Revenue (est.) £18.7m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods $13k (FY, 2023) | Cost of goods $5.1m (FY, 2025) | Cost of goods €2m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $414.7m (FY, 2025) | Gross profit (€1.5m) (FY, 2019) | Gross profit N/A |
Net income | Net income ($10.2m) (FY, 2025) | Net income ($48.1m) (FY, 2023) | Net income ($35.5m) (FY, 2025) | Net income (€10.3m) (FY, 2019) | Net income (£2.6m) (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised $ 12m | Total funding raised $ 50.5m | Total funding raised $ 565m | Total funding raised N/A | Total funding raised $ 57.3m |
For sources of this data, please see the company profile
View Company Profiles
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View companyImmunocore
HQ
Milton, GB
Employees
493
Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases.
View companyMOLOGEN
HQ
Berlin, DE
Employees
47↓ 10% decrease
MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases.
View companyF-star Biotechnology
HQ
Cambridge, GB
Employees
39
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company